반응식
[CH3:1][N:2]1[C:6]2[CH:7]=[CH:8][C:9]([O:11][CH3:12])=[CH:10][C:5]=2[NH:4][C:3]1=[O:13].[Cl:14][CH2:15][CH:16]1[O:21][CH2:20][CH2:19][N:18]([CH2:22][C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[CH2:17]1>>[ClH:14].[CH2:22]([N:18]1[CH2:19][CH2:20][O:21][CH:16]([CH2:15][N:4]2[C:5]3[CH:10]=[C:9]([O:11][CH3:12])[CH:8]=[CH:7][C:6]=3[N:2]([CH3:1])[C:3]2=[O:13])[CH2:17]1)[C:23]1[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=1참가 물질
3
실험 절차
The condensation of 0.1 mol of 1-methyl-5-methoxy-2,3-dihydro-benzimidazol-2-one and 0.1 mol of 2-chloromethyl-4-benzyl-morpholine is carried out in accordance with the procedure of Example 1. 18 g of 4-benzyl-2-(1-methyl-5-methoxy-2,3-dihydrobenzimidazol-2-on-3-yl-methyl)-morpholine hydrochloride are obtained, m.p. 175° C.
출처 및 근거
- ORD 기록
- ord-9571532900a84b3a99b7a5aa91e08c80
- 출처 데이터셋
- uspto-grants-1979_05
- 특허 번호
- US04152434
연결된 노트
불러오는 중…